Back to top
more

Penumbra (PEN)

(Delayed Data from NYSE)

$210.12 USD

210.12
983,441

+12.55 (6.35%)

Updated Aug 23, 2024 04:00 PM ET

After-Market: $209.94 -0.18 (-0.09%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Investors are optimistic about Myriad Genetics (MYGN) due to the performance of its oncology business and product launches.

Bruker (BRKR) Introduces the D6 PHASER Benchtop XRD Platform

Bruker's (BRKR) new D6 PHASER platform is to be used for material analysis and advanced research.

Factors That Make HCA Healthcare (HCA) a Lucrative Bet Now

HCA Healthcare (HCA) remains well-poised for growth on the resumption of elective surgeries, acquisitions and strong cash-generation abilities.

Abbott (ABT) EPD Sales Aid Growth Amid Currency Headwind

Abbott (ABT) continues to make good progress, increasing manufacturing production and recovering market share in the Nutrition business.

Organigram (OGI) Grows in Cannabis Space With SHRED X Heavies

Organigram's (OGI) SHRED X Heavies is not only the first infused pre-roll in the SHRED product portfolio but also joins a lineup of value-driven, convenient and bold-flavored offerings.

Syneos Health (SYNH) Collaborates With uMotif for New Platform

Syneos Health (SYNH) partners with uMotif to deliver the patient-centric eClinical platform.

Zacks.com featured highlights Penumbra, Trip.com, Transportadora de Gas del Sur and Vipshop

Penumbra, Trip.com, Transportadora de Gas del Sur and Vipshop have been highlighted in this Screen of The Week article.

Envista (NVST) Gains From New Acquisitions Amid FX Woes

Envista's (NVST) implant businesses in Europe perform well on the back of disciplined commercial execution.

Here's Why You Should Retain Henry Schein (HSIC) Stock for Now

Investors are optimistic about Henry Schein (HSIC) due to the performance of its dental business.

Medtronic's (MDT) MiniMed 780G System Favored by New Data

Medtronic (MDT) presents the clinical and real-world data on the MiniMed 780G system at ADA Scientific Sessions in San Diego.

Nilanjan Banerjee headshot

Buy These 4 Low-Beta Stocks to Counter the Choppy Market

It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Penumbra (PEN), Trip.com Group (TCOM), Transportadora (TGS) and Vipshop Holdings (VIPS) are poised to gain.

Boston Scientific's (BSX) New Launches Aid Amid Cost Pressure

Boston Scientific (BSX) remains excited about the rest of 2023 and expects to continue to outpace its peers within the EMEA market.

Haemonetics (HAE) Gets FDA Clearance for NexSys PCS Upgrades

Haemonetics (HAE) receives FDA clearance for the advancements made to the NexSys PCS plasma collection system.

CVS Health (CVS) Retail Arm Continues to Grow Amid Rising Costs

CVS Health (CVS) continues to give high priority to digital engagement, after surpassing 50 million unique digital customers in the first quarter.

STERIS (STE) Buys Surgical Instrumentation Platform From BDX

STERIS (STE) announces the buyout of surgical instrumentation assets from Becton, Dickinson and Company in a $540 million transaction.

Zimmer Biomet (ZBH) Gains From Procedure Recovery, New Launches

Zimmer Biomet (ZBH) is encouraged about the early positive impact of the Hip Insight launch.

SenesTech (SNES) New Alliance to Aid Expansion in South Africa

NSPCA is also working on recommending SenesTech's (SNES) ContraPest to private and state entities and to assist with regulatory issues.

Insulet (PODD) Launches the Omnipod 5 AID System in the UK

Insulet (PODD) commercializes its revolutionary Omnipod 5 AID System in the United Kingdom.

Here's Why You Should Retain National Vision (EYE) Stock Now

Investors continue to remain optimistic about National Vision (EYE) due to the expansion of stores and new investments for the improved optometric experience.

Why You Should Retain Walgreens Boots (WBA) Stock for Now

Investors are optimistic about Walgreens Boots (WBA) on a strong focus on strategic priorities.

Neogen (NEOG) Awarded for its Petrifilm Plate Reader Advanced

Neogen (NEOG) receives the prestigious 2023 Red Dot Award for the Petrifilm Plate Reader Advanced in Design category.

Here's Why Investors Should Retain Phibro (PAHC) for Now

Investors are optimistic about Phibro's (PAHC) diversified offerings and booming vaccine business.

Edwards Lifesciences' (EW) TMTT Sales Aid Amid Margin Woes

Edwards Lifesciences (EW) continues to expect the global TAVR opportunity to increase to $10 billion by 2028.

QIAGEN (QGEN) Publishes New Data on QuantiFERON TB Testing

The study on QIAGEN's (QGEN) QuantiFERON-TB Gold Plus confirms the crucial role of CD8 T-cells for a broad immune assessment of TB infection.

Walgreens Boots (WBA) Aids Freenome in Early Cancer Detection

The collaboration between Walgreens Boots (WBA) and Freenome to advance research based on the early detection of cancer.